Targeting cancer cells with mutated KRAS with krasin, a novel synthetic cycloheptapeptide

被引:0
|
作者
Sheikhnejad, R. [1 ]
Tahoori, F. [1 ]
Shokri, B. [1 ]
机构
[1] Oshida Novel Pharmatech, Incubat Ctr Pharmaceut Technol, Tehran, Iran
关键词
D O I
10.1016/S0959-8049(16)61733-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
895
引用
收藏
页码:S208 / S208
页数:1
相关论文
共 50 条
  • [31] Targeting the DNA replication stress phenotype of KRAS mutant cancer cells
    Al Zubaidi, Tara
    Gehrisch, O. H. Fiete
    Genois, Marie-Michelle
    Liu, Qi
    Lu, Shan
    Kung, Jong
    Xie, Yunhe
    Schuemann, Jan
    Lu, Hsiao-Ming
    Hata, Aaron N.
    Zou, Lee
    Borgmann, Kerstin
    Willers, Henning
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] Targeting the DNA replication stress phenotype of KRAS mutant cancer cells
    Tara Al Zubaidi
    O. H. Fiete Gehrisch
    Marie-Michelle Genois
    Qi Liu
    Shan Lu
    Jong Kung
    Yunhe Xie
    Jan Schuemann
    Hsiao-Ming Lu
    Aaron N. Hata
    Lee Zou
    Kerstin Borgmann
    Henning Willers
    Scientific Reports, 11
  • [33] Selective targeting of K-ras mutated colon cancer cells
    Dvory-Sobol, H
    Kunik, T
    Kazanov, D
    Rozenblat, M
    Noyman, EC
    Liberman, E
    Arber, N
    GASTROENTEROLOGY, 2003, 124 (04) : A363 - A364
  • [34] Targeting KRAS for pancreatic cancer treatment
    Der, Channing J.
    CANCER RESEARCH, 2024, 84 (17)
  • [35] Synthesis and Characterization of a Synthetic Antibody Targeting Cancer Cells
    Farbiarz, K.
    Becker, C. F. W.
    JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S148 - S148
  • [36] Selective targeting of cancer cells using synthetic peptides
    Shadidi, M
    Sioud, M
    DRUG RESISTANCE UPDATES, 2003, 6 (06) : 363 - 371
  • [37] Targeting the untargetable KRAS in cancer therapy
    Pingyu Liu
    Yijun Wang
    Xin Li
    ActaPharmaceuticaSinicaB, 2019, 9 (05) : 871 - 879
  • [39] Development of novel nucleic acid drug targeting KRAS to suppress lung cancer
    Murata, Masashi
    Ohno, Shinichiro
    Kuroda, Masahiko
    CANCER SCIENCE, 2021, 112 : 891 - 891
  • [40] Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
    Hiraki, Masayuki
    Nishimura, Junichi
    Takahashi, Hidekazu
    Wu, Xin
    Takahashi, Yusuke
    Miyo, Masaaki
    Nishida, Naohiro
    Uemura, Mamoru
    Hata, Taishi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Soh, Jae-Won
    Doki, Yuichiro
    Mori, Masaki
    Yamamoto, Hirofumi
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e231